Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Step forward in fighting superbugs
P. aeruginosa biofilm

Discovery offers hope for new anti-infective drugs

In a groundbreaking study, researchers from the University of Nottingham have uncovered a new method for tackling a notorious superbug.

Resistant to many conventional antibiotics, Pseudomonas aeruginosa causes a wide range of infections, particularly among hospital patients, and is almost impossible to eradicate from the lungs of cystic fibrosis sufferers.

A research team from the university's Centre for Biomolecular Sciences looked at the ability of bacterial cells to "talk" to each other, using a process known as "quorum sensing" (QS).

This process allows populations of individual bacteria to act as a social group and assess their numerical strength, rather than acting as individuals.

Genes that are essential for for infection are controlled by this process in many disease-causing bacteria.

Scientists found that by interfering with the QS signalling process, it was possible to block bacterial virulence, meaning bacteria is unable to cause infection.

The findings, which have been published in PLOS Pathogens journal, offer hope for the development of new anti-infective drugs which do not kill bacteria, but instead block their ability to cause disease.

Jonas Emsley, professor of macromolecular crystallography, said: "This groundbreaking work establishes a platform for the future evaluation and further development of these new QS inhibitor compounds as potential drugs for the treatment of P. aeruginosa infections."

For the full report, click here.

Image courtesy of the University of Nottingham.

Become a member or log in to add this story to your CPD history

Vets launch new podcast for pet owners

News Story 1
 Two independent vets have launched a podcast to help owners strengthen their bond with pets. Dr Maggie Roberts and Dr Vanessa Howie, who have worked in both veterinary practice and major charities, are keen to use their experience to enable people to give pets a better life.

The venture, called Vets Talking Pets, provides advice and information on a range of topics, including how to select a suitable pet, where to obtain them and how to get the best out of your vet. Maggie and Vanessa will also discuss sensitive subjects, including end-of-life care, raw food diets and the cost of veterinary care.

The podcast can be found on all the usual podcast sites, including Podbean, Apple, Amazon Music and YouTube. 

Click here for more...
News Shorts
VMD issues guidance on AVM-GSL packaging

The Veterinary Medicines Directorate (VMD) has shared advice on its requirements for medicines considered AVM-GSL.

The guidance explains the information that should be on the outer package, and sets out the typical maximum pack size for an AVM-GSL product. It also describes the user-friendly language, structure and phrases required on packaging and product leaflets.

AVM-GSL products do not require discussion between the purchaser and a veterinary professional. This means that clear product information is needed to support sales choices.

The information will be useful for submitting new products to the AVM-GSL category and lowering the distribution category of products from NFA-VPS to AVM-GSL.

The VMD's guidance can be accessed here.